Covered recipient · General Payments record
MARY NOTARO
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2021–2025
$614.76
- Reported across 37 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $303.40 | 19 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $240.69 | 16 |
| Insulet Corporation | $23.08 | 1 |
| Medtronic, Inc. | $20.52 | 1 |
| Alexion Pharmaceuticals, Inc. | $19.11 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Alexion Pharmaceuticals, Inc. | $19.11 | 06/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1202943712 | CMS |
| Amgen Inc. | $14.49 | 05/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227077327 | CMS |
| Amgen Inc. | $3.35 | 05/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227077331 | CMS |
| Amgen Inc. | $2.21 | 06/06/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227077341 | CMS |
| Amgen Inc. | $150.00 | 07/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228343758 | CMS |
| Amgen Inc. | $3.59 | 07/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227077317 | CMS |
| Amgen Inc. | $12.31 | 07/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227077315 | CMS |
| Amgen Inc. | $2.11 | 08/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227077335 | CMS |
| Amgen Inc. | $2.83 | 09/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227077319 | CMS |
| Amgen Inc. | $2.74 | 10/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227077323 | CMS |
| Amgen Inc. | $5.03 | 10/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227077337 | CMS |
| Amgen Inc. | $2.70 | 10/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227077329 | CMS |
| Amgen Inc. | $4.23 | 11/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227077339 | CMS |
| Amgen Inc. | $17.80 | 11/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228343756 | CMS |
| Amgen Inc. | $2.54 | 11/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227077321 | CMS |
| Amgen Inc. | $9.45 | 12/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227077333 | CMS |
| Amgen Inc. | $5.31 | 12/15/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227077325 | CMS |
| Insulet Corporation | $23.08 | 04/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1207080525 | CMS |
| Medtronic, Inc. | $20.52 | 06/27/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1219943672 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2021, 2022, 2023, 2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.